Coronary Artery Disease
DESSOLVE III
A novel ultrathin-strut biodegradable polymer sirolimus-eluting stent vs. a thin-strut permanent polymer everolimus-eluting stent.
Coronary artery disease plus RA exacerbates risk for adverse CV events, mortality
Among patients with coronary artery disease, rheumatoid arthritis was significantly associated with an elevated risk for myocardial infarction, major adverse cardiovascular events and all-cause mortality, according to data.
Survey reveals ‘knowledge gaps’ in coronary artery disease screening pre-kidney transplant
A survey of transplant surgeons and nephrologists practicing in the United States revealed discrepancies in the way coronary artery disease screening is carried out for asymptomatic kidney transplant candidates.
SCAI unveils guidance for complex PCI
At its virtual Scientific Sessions, the Society for Cardiovascular Angiography and Interventions released a statement on optimal PCI practices in patients with complex CAD.
3D image fusion may help diagnose CAD
A novel method that incorporates information from cardiac CT and cardiac MRI aided cardiologists in diagnosing CAD, according to a study published in Radiology: Cardiothoracic Imaging.
MACHINE
CT angiography-derived fractional flow reserve algorithm vs. invasive FFR for suspected or known CAD.
CAC may best risk score for decisions on aspirin for primary prevention
Using coronary artery calcium scores may better define who should receive aspirin for primary prevention than using the Pooled Cohort Equations, researchers reported in Circulation.
In very low LVEF, CABG has lower MACE, mortality rates vs. PCI
Patients with severely reduced left ventricular ejection fraction and CAD who underwent PCI had higher rates of MACE and mortality compared with those who underwent CABG, according to a study published in JAMA Cardiology.
Symptoms, stress test findings of patients with ischemia, nonobstructive CAD can change over time
In the CIAO ancillary study of patients who were screened for the ISCHEMIA trials but were excluded because they had ischemia but no obstructive CAD, stress echocardiography results and angina frequency changed over time, researchers reported at the virtual American College of Cardiology Scientific Session.
Prognosis of patients with ischemia, nonobstructive CAD can change over time
In the CIAO ancillary study of patients who were screened for the ISCHEMIA trials but were excluded because they had ischemia but no obstructive CAD, stress echocardiography results and angina frequency changed over time, researchers reported at the virtual American College of Cardiology Scientific Session.